IP21-23: Clinical evaluation of AI-based software for predicting pharmacologic response in benign prostatic hyperplasia

IP21-23: Clinical evaluation of AI-based software for predicting pharmacologic response in benign prostatic hyperplasia

Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!